COVID-19 vaccine
COVID-19 vaccine iStock

Pharmaceutical giant Pfizer now claims that its coronavirus vaccine being tested is 95% effective, above the previous estimate of 90%.

The latest test results showed no signs of serious side effects, the company said, with the late-stage vaccine trials showing an improved level of effectiveness of 95%, including 94% among the elderly.

Pfizer is reportedly just days away from filing an application with the US Food and Drug Administration for emergency authorization for the two-dose coronavirus vaccine.

Last week, preliminary results showed the Pfizer – BioNTech vaccine for the coronavirus to be 90% effective.

The initial study showed that among the 43,538 total participants, seven days after the second dose was administered - and 28 days after the first dose - the vaccinated group was found to have 90% fewer symptomatic cases of the coronavirus than the control group.

Days later, a rival company, Moderna, announced that its coronavirus vaccine had been rated as being 94.5% effective.

The Moderna tests included 30,000 participants, half of whom were given a placebo, and half of whom were given the vaccine. Of the control group, 90 became infected with the coronavirus, including 11 with severe cases of the virus.

Join our official WhatsApp group